Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating expenses
Research and development	$ 21,185	$ 14,117
General and administrative	15,956	13,504
Total operating expenses	37,141	27,621
Operating loss	(37,141)	(27,621)
Impairment charge on investment in equity securities	0	(1,710)
Interest income	2,377	4,050
Other expense, net	(6)	(223)
Loss before income taxes	(34,770)	(25,504)
Income taxes benefit	0	0
Net loss	$ (34,770)	$ (25,504)
Net loss per share of common stock - basic (in dollars per share)	$ (4.04)	$ (3.04)
Net loss per share of common stock - diluted (in dollars per share)	$ (4.04)	$ (3.04)
Weighted average shares outstanding used to compute net loss per share- basic (in shares)	8,611,321	8,390,618
Weighted average shares outstanding used to compute net loss per share - diluted (in shares)	8,611,321	8,390,618